Your trusted source for investing success

Tag: pharmaceuticals

Cannabis ETFs – Should you invest?

Cannabis ETFs – Should you invest?

Cannabis stocks can be precarious, but what about cannabis ETFs? Here we look into which cannabis ETFs are in the market and whether or not they are a viable option in cannabis investment.

Top Pharmaceutical ETFs

Top Pharmaceutical ETFs

To help make investors aware of some of their options when looking at investing in the pharmaceutical sector, the Investing News Network took a look at the five top pharmaceutical ETFs.

Nuvo Subsidiary Obtains Rights to Resultz

Nuvo Pharmaceuticals (TSX:NRI; OTCQX:NRIFF) announced its Ireline subsidiary acquired the U.S. rights of Resultz from Piedmont Pharmaceuticals.

As quoted in the press release:
The acquisition includes all U.S. product and intellectual property rights and is a complementary follow-on to Nuvo’s acquisition of the global, ex-U.S. Resultz product rights announced on January 2, 2018.  Nuvo now owns

Galaxy Digital, First Coin and Bradmer Pharmaceuticals Announce Business Combination and Establishment of Blockchain, Digital Asset and Cryptocurrency Platform

Bradmer Pharmaceuticals (NEX:BMR.H) has announced that it has entered into a letter of intent dated January 9, 2018 with Galaxy Digital LP and First Coin Capital to form a new enterprise in the blockchain, digital asset and cryptocurrency space.

As quoted in the press release:

 
The series of transactions contemplated by the

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has partnered with Mr. Charles (Chuck) Austin and JK Advisors in order to scale up operational

Phivida Launches High Performance Nano-CBD™

Phivida Launches High Performance Nano-CBD™

Phivida Holdings Inc. (CSE:VIDA) is pleased to announce the launch of its flagship line of high performance Nano-CBD™ (nanoencapsulated-cannabidiol) infused beverages into the US athletic and sports medicine market.

Phivida Nano-CBD™ Sport line of beverages are designed to maximize physical, mental performance for athletes, fitness professionals and everyday health conscious consumers.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
The Case for Investing in Biotech

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/investing-in-biotech/